4215.T
Latest Trade
672.00JPYChange
-1.00(-0.15%)Volume
55,500Today's Range
-
679.0052 Week Range
-
724.00As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 673.00 |
|---|---|
Open | 673.00 |
Volume | 55,500 |
3M AVG Volume | 1.62 |
Today's High | 679.00 |
Today's Low | 669.00 |
52 Week High | 724.00 |
52 Week Low | 533.00 |
Shares Out (MIL) | 97.37 |
Market Cap (MIL) | 65,520.00 |
Forward P/E | -- |
Dividend (Yield %) | 4.46 |
Ci Takiron Corporation's Yosuke Minamitani To Be Chairman And CEO, Kazuya Saito To Be President And COO
CI Takiron to take over business from two units
CI Takiron announces change of corporate auditor
C.I. TAKIRON Corporation is a Japan-based company mainly engaged in the manufacture, processing and sale of resin products and composite products. The Company has four business segments. The Building Materials segment is engaged in the manufacture and sale of polycarbonate products, daylighting unit products, light emitting diode (LED) signs, LED indicators, fiber reinforced plastics (FRP) products and other products. The Environmental Materials segment is engaged in the manufacture and sale of agricultural materials, packing strings and ropes, irrigation tubes, civil engineering sheets, hard resin plates and other products. The High Functional Materials segment is engaged in the manufacture and sale of polycarbonate plates, functional resin plates, cutting materials, polypropylene (PP) filter plates, acetate sheets, flexible magnets and other products. The Functional Film segment is engaged in the manufacture and sale of heat shrink films, plastic bags, chuck tapes and other products.
Industry
Chemicals - Plastics & Rubber
Executive Leadership
Yosuke Minamitani
Chairman of the Board, Chief Executive Officer, Representative Director
Katsumori Hyodo
Chairman
Kazuya Saito
President, Chief Operating Officer, Representative Director
Tetsushi Ishizuka
Vice Chairman
Toshiya Ohkubo
Executive Officer, Director of Finance & Accounting
Price To Earnings (TTM) | 11.87 |
|---|---|
Price To Sales (TTM) | 0.44 |
Price To Book (MRQ) | 0.89 |
Price To Cash Flow (TTM) | 6.48 |
Total Debt To Equity (MRQ) | 6.92 |
LT Debt To Equity (MRQ) | 0.00 |
Return on Investment (TTM) | 6.60 |
Return on Equity (TTM) | 4.10 |
* Says the co plans to set up new unit on July 3, to take over part of medical business from the co
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.